Konstanze Döhner

1998–2025 年に発表

192
論文数
47,510
被引用数
105
h 指数
186
i10 指数

被引用数

Konstanze Döhner の年別被引用数1984 年: 被引用 2 件1999 年: 被引用 7 件2000 年: 被引用 13 件2001 年: 被引用 17 件2002 年: 被引用 52 件2003 年: 被引用 54 件2004 年: 被引用 69 件2005 年: 被引用 169 件2006 年: 被引用 215 件2007 年: 被引用 218 件2008 年: 被引用 283 件2009 年: 被引用 293 件2010 年: 被引用 335 件2011 年: 被引用 389 件2012 年: 被引用 395 件2013 年: 被引用 388 件2014 年: 被引用 464 件2015 年: 被引用 433 件2016 年: 被引用 487 件2017 年: 被引用 515 件2018 年: 被引用 446 件2019 年: 被引用 1,802 件2020 年: 被引用 1,909 件2021 年: 被引用 1,691 件2022 年: 被引用 1,307 件2023 年: 被引用 1,092 件2024 年: 被引用 1,455 件2025 年: 被引用 623 件2026 年: 被引用 11 件1985〜1998 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,513 件、この内訳の 26.8%ドイツ: 引用元論文 1,673 件、この内訳の 9.9%中国: 引用元論文 1,280 件、この内訳の 7.6%イギリス: 引用元論文 1,185 件、この内訳の 7%イタリア: 引用元論文 1,005 件、この内訳の 6%フランス: 引用元論文 804 件、この内訳の 4.8%スペイン: 引用元論文 557 件、この内訳の 3.3%オランダ: 引用元論文 522 件、この内訳の 3.1%カナダ: 引用元論文 508 件、この内訳の 3%日本: 引用元論文 392 件、この内訳の 2.3%スイス: 引用元論文 386 件、この内訳の 2.3%オーストラリア: 引用元論文 382 件、この内訳の 2.3%
0%26.8%その他 21.6%

分野

  • Medicine67.6%
  • Biochemistry, Genetics and Molecular Biology28.5%
  • Immunology and Microbiology2.1%
  • Computer Science0.6%
  • Chemistry0.2%
  • Mathematics0.2%
  • その他0.8%

トピック

  • Acute Myeloid Leukemia Research16.6%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment5.9%
  • Chronic Myeloid Leukemia Treatments4.1%
  • Cancer Genomics and Diagnostics3.6%
  • Chronic Lymphocytic Leukemia Research3.5%
  • Epigenetics and DNA Methylation3.5%
  • その他62.8%

共著者

全論文

検索で開く
  1. Genomic Classification and Prognosis in Acute Myeloid Leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2016 被引用: 4,363

  2. Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 被引用: 2,198

  3. 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Farhad Ravandi, Christophe Roumier, Marion Subklewe, Felicitas Thol, Arjan A. van de Loosdrecht, Bert A. van der Reijden, Adriano Venditti, Agnieszka Wierzbowska, Peter J.M. Valk, Brent L. Wood, Roland B. Walter, Christian Thiede, Konstanze Döhner, Gail J. Roboz, Jacqueline Cloos - Blood 2021 被引用: 718

  4. Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hartmut Link, Maria Grazia Kropp, Alessandro Rambaldi, Giorgio La Nasa, Mario Luppi, Fabio Ciceri, Olimpia Finizio, Adriano Venditti, Francesco Fabbiano, Konstanze Döhner, Michaela Sauer, Arnold Ganser, Sergio Amadori, Franco Mandelli, Hartmut Döhner, Gerhard Ehninger, Richard F. Schlenk, Uwe Platzbecker - New England Journal of Medicine 2013 被引用: 1,606

  5. Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Blood 2018 被引用: 1,029

  6. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2005 被引用: 2,991

  7. Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia

    著者: , , , , , , , , - New England Journal of Medicine 2000 被引用: 3,296

  8. Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia

    著者: , , , , , , , , , , , , , - Science 2020 被引用: 271

  9. Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cindy Zhang, Rinnat M. Porat, Diana M. Merino, Jonathan D. Wasserman, Nada Jabado, Adam M. Fontebasso, Lars Bullinger, Frank G. Rücker, Konstanze Döhner, Hartmut Döhner, Jan Köster, Jan J. Molenaar, Rogier Versteeg, Marcel Kool, Uri Tabori, David Malkin, Andrey Korshunov, Michael D. Taylor, Peter Lichter, Stefan M. Pfister, Jan O. Korbel - Cell 2012 被引用: 878

  10. Unified classification and risk-stratification in Acute Myeloid Leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2022 被引用: 175

  11. SEURAT: Visual analytics for the integrated analysis of microarray data

    著者: , , , , , , , - BMC Medical Genomics 2010 被引用: 257

  12. A Single Oncogenic Enhancer Rearrangement Causes Concomitant EVI1 and GATA2 Deregulation in Leukemia

    著者: , , , , , , , , , , , , , , , , , , , , - Cell 2014 被引用: 720

  13. TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome

    著者: , , , , , , , , , , , , , , , , , , , , , - Blood 2011 被引用: 678

  14. Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hartmut Döhner, Arnold Ganser, Michael Heuser - Blood 2018 被引用: 301

  15. Genomics of Acute Myeloid Leukemia Diagnosis and Pathways

    著者: , , - Journal of Clinical Oncology 2017 被引用: 585

  16. Clonal evolution of acute myeloid leukemia with FLT3-ITD mutation under treatment with midostaurin

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2021 被引用: 158

  17. Effect of Mutation Order on Myeloproliferative Neoplasms

    著者: , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2015 被引用: 575

  18. Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ross L. Levine, Ari Melnick, Christopher E. Mason - Nature Medicine 2016 被引用: 401

  19. Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood Advances 2021 被引用: 119

  20. Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sergio Amadori, Insa Gathmann, Axel Benner, Céline Pallaud, Richard M. Stone, Hartmut Döhner, Clara D. Bloomfield - Blood 2019 被引用: 193

  21. Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09–09): a randomised, open-label, multicentre, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter Paschka, Verena I. Gaidzik, Maral Saadati, Axel Benner, Richard F. Schlenk, Konstanze Döhner, Arnold Ganser, Hartmut Döhner, Daniela Weber, Julia Krzykalla, Walter Fiedler, Michael W.M. Kühn, Thomas Schroeder, Karin Mayer, Michael Lübbert, Mohammad Amen Wattad, Katharina S. Götze, Lars Fransecky, Elisabeth Koller, Gerald Wulf, Jan Schleicher, Mark Ringhoffer, Richard Greil, Bernd Hertenstein, Jürgen Krauter, Uwe M. Martens, David Nachbaur, Maisun Abu Samra, Sigrid Machherndl-Spandl, Nadezda Basara, Claudia Leis, Anika Schrade, Silke Kapp‐Schwoerer, Sibylle Cocciardi, Lars Bullinger, Felicitas Thol, Michael Heuser, Peter Paschka, Verena I. Gaidzik, Maral Saadati, Axel Benner, Richard F. Schlenk, Konstanze Döhner, Arnold Ganser - The Lancet Haematology 2023 被引用: 57

  22. Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Hallek, Hartmut Döhner - Blood 2014 被引用: 507

  23. Monitoring of Minimal Residual Disease in NPM1 -Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study Group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2011 被引用: 394

  24. Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chiara Frairia, Enrico Maria Pogliani, Claudio Fozza, Alfonso Maria D’Arco, Nicola Di Renzo, Agostino Cortelezzi, Francesco Fabbiano, Konstanze Döhner, Arnold Ganser, Hartmut Döhner, Sergio Amadori, Franco Mandelli, Gerhard Ehninger, Richard F. Schlenk, Francesco Lo‐Coco - Journal of Clinical Oncology 2016 被引用: 392